Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents
Public ClinicalTrials.gov record NCT01686607. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter Cohort Study of the Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents
Study identification
- NCT ID
- NCT01686607
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Astellas Pharma Europe B.V.
- Industry
- Enrollment
- 40,110 participants
Conditions and interventions
Conditions
Interventions
- Parenteral micafungin application Drug
- Other parenteral antifungal drugs Drug
Drug
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2012
- Primary completion
- Apr 29, 2018
- Completion
- Apr 29, 2018
- Last update posted
- Oct 20, 2024
2012 – 2018
United States locations
- U.S. sites
- 6
- U.S. states
- 5
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site US4 | Baltimore | Maryland | 21205 | — |
| Site US2 | Boston | Massachusetts | 02119 | — |
| Site US6 | Ann Arbor | Michigan | 48109 | — |
| Site US3 | Durham | North Carolina | 27710 | — |
| Site US5 | Philadelphia | Pennsylvania | 19104 | — |
| Site US1 | Pittsburgh | Pennsylvania | 15213 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01686607, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 20, 2024 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01686607 live on ClinicalTrials.gov.